Newtyn Management, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$935.8M
Q ending 2026-03-31
Prior quarter
$951.8M
Q ending 2025-12-31
Change
-1.7% QoQ · +48.0% YoY
Positions
33
reported holdings

Largest positions

All 33 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Enviri CorpHA7Shares$108.0M5.5M
Theravance Biopharma IncShares$78.6M4.8M
Quidelortho CorpQDELShares$74.9M4.6M
Array Digital InfrastructureADShares$74.6M1.6M
Vistance Networks IncVISNShares$68.5M3.8M
Indivior Pharmaceuticals IncINDVShares$61.0M2.0M
Apartment Invt & Mgmt CoAIVShares$49.7M12.2M
Teleflex IncorporatedTFXShares$47.8M400K
Resolute Hldgs Mgmt IncRHLDShares$39.3M242K
Cannae Hldgs IncCNNEShares$37.1M3.3M
Par Technology CorpPARShares$36.4M2.7M
Usa Rare Earth IncUSARShares$35.4M2.3M
Weave Communications IncWEAVShares$32.3M7.0M
Cogent Comm Holdings IncCCOIShares$30.1M1.6M
Magnera CorpMAGNShares$26.2M2.8M
Brightview Hldgs IncBVShares$24.8M2.1M
Compass Minerals Intl IncCMPShares$18.0M770K
Spectrum Brands Holdings IncSPBShares$13.6M185K
Rocket Pharmaceuticals IncRCKTShares$11.3M3.2M
1 800 Flowers Com IncFLWSShares$10.6M3.5M
Destiny Tech100 IncDXYZShares$9.2M345K
Ni Hldgs IncNODKShares$8.6M670K
Ultragenyx Pharmaceutical InRAREShares$8.4M400K
Grail IncGRALShares$7.8M150K
Ataibeckley IncATAIShares$6.3M1.8M
Franklin Str Pptys CorpFSPShares$4.8M7.2M
Zooz Strategy LtdShares$4.0M13.4M
Mereo Biopharma Group PlcMREOShares$2.3M7.1M
Wave Life Sciences LtdShares$2.2M300K
Green Dot CorpGDOTShares$1.6M143K
Uniqure NvShares$1.4M88K
Elme CommunitiesELMEShares$624K310K
Seritage Growth PptysSRGShares$116K41K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.